IP Verse

Mycoplasma Hyopneumoniae Vaccine - EP2833908

The patent EP2833908 was granted to Zoetis on Jan 5, 2022. The application was originally filed on Apr 3, 2013 under application number EP13715881A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2833908

ZOETIS
Application Number
EP13715881A
Filing Date
Apr 3, 2013
Status
Granted And Under Opposition
Dec 3, 2021
Publication Date
Jan 5, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM VETMEDICAOct 3, 2022D YOUNGADMISSIBLE

Patent Citations (45) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2011IB55003
DESCRIPTIONEP0595436
DESCRIPTIONES2074950
DESCRIPTIONGB2282811
DESCRIPTIONUS2011150913
DESCRIPTIONUS5620691
DESCRIPTIONUS5695766
DESCRIPTIONUS5788962
DESCRIPTIONUS6110467
DESCRIPTIONUS6162435
DESCRIPTIONUS6165995
DESCRIPTIONUS6251397
DESCRIPTIONUS6251404
DESCRIPTIONUS6268199
DESCRIPTIONUS6380376
DESCRIPTIONUS6500662
DESCRIPTIONUS6592873
DESCRIPTIONUS6610310
DESCRIPTIONUS6773908
DESCRIPTIONUS6977078
DESCRIPTIONUS7223854
DESCRIPTIONUS7264802
DESCRIPTIONUS7264957
DESCRIPTIONUS7279166
DESCRIPTIONUS7419806
DESCRIPTIONUS7517976
DESCRIPTIONUS7575752
DESCRIPTIONWO03049703
DESCRIPTIONWO9221375
DESCRIPTIONWO9303760
DESCRIPTIONWO9307898
DESCRIPTIONWO9314196
EXAMINATIONUS2012052514
INTERNATIONAL-SEARCH-REPORTWO2007116032
INTERNATIONAL-SEARCH-REPORTWO2009126356
INTERNATIONAL-SEARCH-REPORTWO2011141443
INTERNATIONAL-SEARCH-REPORTWO9628472
OPPOSITIONEP2217271
OPPOSITIONEP2327787
OPPOSITIONUS2009317423
OPPOSITIONUS2012052514
OPPOSITIONUS8546149
OPPOSITIONUS9687544
OPPOSITIONWO2009127684
OPPOSITIONWO2012025612

Non-Patent Literature (NPL) Citations (21) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- ALLAN G M, ELLIS J A, "PORCINE CIRCOVIRUSES: A REVIEW", JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, US , (20000101), vol. 12, no. 01, ISSN 1040-6387, pages 03 - 14, XP001023034
OPPOSITION- Anonymous, "Veterinary Drug - MYCOBUSTER AR PLUS®", Product Data Sheet (in Japanese. English translation enclosed), (20170601), pages 1 - 2, XP055973688
OPPOSITION- Anonymous, "Veterinary Drug - MYCOBUSTER®", Product Data Sheet (in Japanese. English translation enclosed), (20171101), pages 1 - 2, XP055973679
OPPOSITION- Antibody Purification Handbook, (20020101), pages 1 - 112, XP055762642
OPPOSITION- Boehringer Ingelheim, "Ingelvac® CircoFLEX - MycoFLEX™", MATERIAL SAFETY DATA SHEET, (20080623), XP055306404
OPPOSITION- Darrell Neuberger, Richard Swalla, "Innovation and Technology Contributing to the Development of Fostera™ PCV MH", Zoetis Technical update, (20131001), pages 1 - 4, XP055565772
OPPOSITION- Eichmeyer Marc A., Roof M. B., Piontkowski M. D., Robb E. J., "Efficacy of Ingelvac® PRRS MLV when rehydrated with a combination of Ingelvac MycoFLEX® and Ingelvac CircoFLEX®", Allen D. Leman Swine Conference, (20100901), page 175, XP055896489
OPPOSITION- Emea Chmp, "Note guidance on the clinical evaluation of vaccines", CHMP/VWP/164653/2005, (20050517), pages 1 - 23, XP055973671
OPPOSITION- G Haiwick, M Eichmeyer, M Roof And E Robb, "Trivalent vaccine mixture protects against simultaneous challenge with M. hyopneumoniae, PCV2, and PRRS virus", Allen D. Leman Swine Conference, (20100101), page 176, XP055565903
OPPOSITION- "Guidance of Industry for the Evaluation of combination vaccines for preventable diseases: production, testing and clinical studies", (19970401), pages 1 - 19, XP055584273
OPPOSITION- Machin Yeleiny, Yeosvany Cabrera, José Miguel Fernández, Ricardo Pina, Yoel Pérez, Onel Valdivia, María T. Barceló, Lisbet Ulloa, Liudmila Benítez, Ronny Camacho, Duniesky Martínez, Enrique R. Pérez, "DEVELOPMENT AND VALIDATION OF AN IMMUNOENZYMATIC ASSAY FOR PIG IGG QUANTIFICATION IN SERUM SAMPLES", JVT, (20210401), vol. 27, no. 2, XP055973711
OPPOSITION- M A O'dea, "Porcine circovirus infection", Australia and New Zealand Standard Diagnostic Procedure, (20100701), pages 1 - 20, XP055565863
OPPOSITION- Troy J Kaiser, Therese K Yonkers, Lucas P Taylor And Rika Jolie, "Mycoplasma hyopneumoniae efficacy and field safety evaluation of a 3-way Haemophilus parasuis/Mycoplasma hyopneumoniae combination bacterin", Allen D. Leman Swine Conference - Recent Research Reports, page 31, XP055565848
OPPOSITION- Lindmark, R. ; Thoren-Tolling, K. ; Sjoquist, J., "Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera", Journal of Immunological Methods, NL , (19830101), vol. 62, no. 1, doi:10.1016/0022-1759(83)90104-7, ISSN 0022-1759, pages 1 - 13, XP023676342
OPPOSITION- FREUNDT, "Culture Media for Classic Mycoplasms", Methods in Mycoplasmology, (19830000), doi:10.1016/B978-0-12-583801-6.50029-9, pages 127 - 135, XP055321252
OPPOSITION- Escribano D., Gutiérrez A.M., Martínez Subiela S., Tecles F., Cerón J.J., "Validation of three commercially available immunoassays for quantification of IgA, IgG, and IgM in porcine saliva samples", Research in veterinary science, GB , (20121001), vol. 93, no. 2, doi:10.1016/j.rvsc.2011.09.018, ISSN 0034-5288, pages 682 - 687, XP055973703
OPPOSITION- Okada, M. Asai, T. Ono, M. Sakano, T. Sato, S., "Cytological and immunological changes in bronchoalveolar lavage fluid and histological observation of lung lesions in pigs immunized with Mycoplasma hyopneumoniae inactivated vaccine prepared from broth culture supernate", Vaccine, AMSTERDAM, NL , (20000601), vol. 18, no. 25, doi:10.1016/S0264-410X(00)00077-3, ISSN 0264-410X, pages 2825 - 2831, XP004203572
OPPOSITION- M. Okada, T. Asai, M. Ono, T. Sakano, S. Sato, "Protective Effect of Vaccination with Culture Supernate of M. hyopneumoniae against Experimental Infection in Pigs", Journal of Veterinary Medicine Series B, (20000901), vol. 47, no. 7, doi:10.1046/j.1439-0450.2000.00372.x, ISSN 09311793, pages 527 - 533, XP055067074
OPPOSITION- J Gillespie, T. Opriessnig, X.J. Meng, K. Pelzer, And V. Buechner-Maxwell, "Porcine Circovirus Type 2 and Porcine Circovirus-Associated Disease", J. Vet. Intern Med., (20090101), vol. 23, doi:10.1111/j.1939-1676.2009.0389.x, pages 1151 - 1163, XP055565869
OPPOSITION- Munenori Okada, Tetsuya Sakano, Kazuhiro Senna, Takashi Maruyama, Junichi Murofushi, Hiroshi Okonogi, Shizuo Sato, "Evaluation of Mycoplasma hyopneumoniae Inactivated Vaccine in Pigs under Field Conditions", Journal of veterinary medical science, JP , (19990101), vol. 61, no. 10, doi:10.1292/jvms.61.1131, ISSN 0916-7250, pages 1131 - 1135, XP055565881
OPPOSITION- Hu-Cheng Zhang, Jun Yang, Guo-Wei Yang, Xiao-Jie Wang And Hai-Tao Fan, "Production of recombinant protein G through high-density fermentation of engineered bacteria as well as purification", Mol Med Reports, (20150101), vol. 12, doi:10.3892/mmr.2015.3688, pages 3132 - 3138, XP055584457

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents